Berkeley Energy Limited (ASX:BKY) Addresses Share Price and Trading Volume Surge
Berkeley Energy Limited (ASX:BKY) addresses increased share price and trading volume, detailing compliance and key developments in Spain’s nuclear sector.
Tag: Regulatory News & Compliance
I Synergy Group Limited (ASX:IS3) Requests Trading Halt for Capital Raising
I Synergy Group Limited (ASX:IS3) requests a trading halt to complete a proposed capital raising, expected to resume by 27 March 2025.
Telix Pharmaceuticals Limited (ASX:TLX) Receives FDA Approval for Gozellix®
Telix Pharmaceuticals (ASX:TLX) announces FDA approval for Gozellix®, expanding prostate cancer imaging access in the U.S.
WiseTech Global Limited (ASX:WTC) Announces Board Review Update
WiseTech Global Limited (ASX:WTC) provides an update on the ongoing board review and governance measures amidst investigations involving Executive Chair Mr Richard White.
C29 Metals (ASX:C29) Expands Ulytau Project with New Exploration Licence
C29 Metals (ASX:C29) secures a new exploration licence, expanding the Ulytau Project footprint by 116 km² in Kazakhstan.
Imugene Limited (ASX:IMU) Granted FDA Fast Track Designation for Azer-cel
Imugene Limited (ASX:IMU) secures FDA Fast Track designation for its allogeneic CAR T-cell therapy azer-cel, advancing treatment for relapsed or refractory diffuse large B-cell lymphoma.
New Zealand King Salmon (ASX:NZK) Reports Increased Mortality Affecting FY26 Harvest
New Zealand King Salmon (ASX:NZK) faces higher sea farm mortality impacting FY26 harvest projections while maintaining FY25 financial guidance.
Orthocell Limited (ASX:OCC) Receives Singapore Regulatory Approval for Striate+
Orthocell Limited (ASX:OCC) secures Singapore’s regulatory approval for Striate+, boosting its global market expansion and sales growth.
Dropsuite Limited (ASX:DSE) Faces Application to Takeovers Panel
Harvest Lane Asset Management files application with the Takeovers Panel concerning Dropsuite Limited (ASX:DSE)’s shareholder activities amid a proposed acquisition.
InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.